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Abstract
Background: Prolonged wound healing is a complication of diabetes that contributes to mortality. Impaired
wound healing occurs as a consequence of excessive reactive oxygen species (ROS) production. Whey protein (WP)
is able to reduce the oxygen radicals and increase the levels of the antioxidant glutathione. Thus, the aim of this
study was to determine whether dietary supplementation with WP could enhance normal inflammatory responses
during wound healing in diabetic rats. Animals were assigned into a wounded control group (WN), a wounded
diabetic group (WD) and a wounded diabetic group orally supplemented with whey protein (WDWP) at a dose of
100 mg/kg body weight.
Results: Whey protein was found to significantly decrease the levels of malondialdehyde (MDA), nitric oxide (NO)
and ROS. A significant restoration of the glutathione level was observed in WDWP rats. During the early wound
healing stage, IL-1b, TNF-a, IL-6, IL-4 and neutrophil infiltration were significantly decreased in WD mice. WP
supplementation was found to restore the levels of these inflammatory markers to the levels observed in control
animals. In addition, the time required for wound healing was significantly prolonged in diabetic rats. WP was
found to significantly decrease the time required for wound healing in WDWP rats.
Conclusion: In conclusion, dietary supplementation with WP enhances the normal inflammatory responses during
wound healing in diabetic mice by restoring the levels of oxidative stress and inflammatory cytokines.
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Background
The ability of animals to repair wounds is critical for
survival after injury [1]. A multitude of cellular events,
such as cell proliferation, cell migration, contraction and
extracellular matrix degradation and synthesis, must
occur to achieve wound closure and regeneration of the
injured dermis [2]. These events rely on the temporal
expression and activation ofav a r i e t yo fp r o t e i n s ,s u c h
as growth factors, cytokines and matrix metalloprotei-
nases [3].
Wound healing is initiated by an inflammatory phase
that is followed by a proliferation phase, particularly the
proliferation of fibroblasts and endothelial cells. The last
phase involves the production and reorganization of the
extracellular matrix, leading to repair or regeneration.
The inflammatory phase leads to the recruitment of leu-
kocytes that produce growth factors and remove debris
from the wound [4-7]. The healing process requires an
interaction between inflammatory cells and biochemical
mediators, which is stimulated by a number of mitogens
and chemotactic factors [4].
The generation of oxygen radicals is normally
balanced by the presence of adequate endogenous anti-
oxidant defenses [8]. Oxidative stress has been impli-
cated in the pathology of diabetes mellitus [9,10], a
disease marked by a prolonged inflammatory period that
increases the time required for recovery. Impaired
wound healing occurs as a consequence of excessive
ROS production. Identification of the dietary proteins
that enhance skin repair in diabetes may contribute to
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studies have confirmed the role of glutathione, which is
increased by dietary WP, as a powerful antioxidant
[11,12]. WP is able to reduce the effects of oxygen radi-
cals and lipid peroxidation by increasing the activity of
the antioxidant glutathione, thus stimulating epitheliza-
tion and the proliferation of fibroblasts as well as
increasing the secretion of both pro- and post-inflam-
matory cytokines. WP has been found to significantly
suppress hydroperoxide and ROS levels in leukocytes,
liver and cutaneous tissues in mice by restoring the anti-
oxidant glutathione [13].
In addition, WP contains all of the essential and non-
essential amino acids and is a good source of glutamine
and the branched-chain amino acids that are necessary
for cell growth [14]. The branch-chained amino acids
leucine, isoleucine and valine promote the healing of
bones, skin and muscle tissues. The amino acid proline
aids in the production of collagen, thereby healing carti-
lage and strengthening joints, tendons and cardiac mus-
cle [15].
We hypothesized that wound healing in diabetic ani-
mals could be improved by supplementing their diets
with WP. Data from our previous work indicate that
WP increases the capacity of non-diabetic animals to
heal wounds [16]. Additionally, our recent study [13]
revealed the potential effects of WP on immune pro-
cesses, including the regulation of many cytokines. We
also found that the ability of peripheral blood mononuc-
lear cells (PBMCs) to proliferate in response to stimula-
tion with different antigens was significantly increased
in the WP-treated group [17].
Results
Impaired wound healing in diabetes occurs as a conse-
quence of excessive ROS production. WP is known to
result in the reduction of the oxygen radicals and
increase levels antioxidant glutathione. Thus, we aimed
to accelerate the wound healing process using a dietary
supplementation of whey protein in a streptozotocin-
diabetic rat model. External indices of the wound size
over time, oxidative stress and the inflammatory mar-
kers were analyzed in this study to evaluate the effect of
whey protein on this vital process.
Whey protein enhanced wound closure rate in diabetic
models
T h et i m er e q u i r e dt oh e a lw o u n d si nd i a b e t i cr a t sw a s
prolonged. Interestingly, results showed that the time
required to heal wounds was significantly shortened in
WDWP rats comparing to the diabetic rats. All
wounded diabetic animals fed whey protein achieved
complete healing by day 8. Within 8 days of wounding,
100% of the WDWP and WN rats’ wounds showed
complete closure, whereas only 20% of WD wounds
exhibited complete closure by D12 (Table 1). In addi-
tion, 30% of the diabetic rats did not survive past day
10.
On day 2, no significant differences were observed
among different rat groups. However, on day 3, it was
clear that the wound closure rate in the WD animals
was significantly delayed due to the effect of diabetes on
the inflammatory stage of healing. WP was found to sig-
nificantly (P < 0.05) accelerate the closure rate in dia-
betic rats (WDWP) by 2.5 fold more than that of the
diabetic rats (WD) on days 3 and 6, and the closure rate
in WDWP rats was also significantly higher than the
control rats on day 3 (Figure 1A).
In addition, wound contraction was obvious in the
wounds of the WDWP group at day 3 and in the
wounds of control rats at day 5. However, no wound
contraction was observed in the diabetic wound group
until day 10, and the contraction was poor in two rats.
In summary, the rate of wound closure in the whey pro-
tein supplemented diabetic group was significantly faster
than those of the diabetic group (ex. on Figure 1B).
Whey protein improved parameters of oxidative stress
Because oxidative stability is vital for normal wound
healing, we monitored the oxidative stress in WN, WD
and WDWP rats. As expected, all oxidative markers
were significantly elevated in the diabetic rats. A signifi-
cant inhibition (P < 0.05) of the oxidative parameters
was observed in the WDWP rats. Statistical analysis
revealed that the rat group supplemented with WP
showed a significant decrease in the level of MDA com-
pared to the control mice. We also observed a signifi-
cant suppression of both NO and ROS in the WDWP
group. Interestingly, glutathione was significantly
restored (P < 0.05) in the WDWP rats (Figure 2), nearly
reaching the level observed in control animals.
Whey protein stimulated inflammatory cytokines
Activated tissue macrophages secrete three cytokines
(IL-1b,T N F - a and IL-6) that induce many of the loca-
lized and systemic changes observed in the acute phase
Table 1 Percentage of animals that achieved complete
wound healing by day 6 (D6), day 8 (D8) and day 10
(D10) in non-diabetic normal rats (WN), diabetic rats
(WD) and diabetic rats supplemented with whey protein
(WDWP) and the mortality rate in these groups by D10
Complete Healing % Mortality at D10 %
D6 D8 D10
WN 40% 100% 100% 0%
WD 0% 0% 20% 30%
WDWP 40% 100% 100% 0%
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tory cytokines IL-1b and TNF-a were measured to
determine their roles in the inflammatory stage of the
wound healing process. The level of IL-1b peaked at 6 h
in both the control WN rats and the WDWP rats (Fig-
ure 3A), but low levels of IL-1b were observed in the
WD rats until 24 h. Moreover, the level of IL-1b in the
WD group was significantly lower than the levels of IL-
1b in either the control or WDWP rats. Notably, the
pattern of TNF-a levels was similar to that of IL-1b in
all groups (Figure 3B). The level of TNF-a was signifi-
cantly lower in WD rats compared to control or
WDWP rats.
At the beginning of the inflammatory stage, IL-6 is
secreted by macrophages locally and systemically and
induces many changes, including changes in vascular
permeability [18]. Therefore, we examined IL-6 levels 6
h after wounding. The IL-6 level was significantly
elevated in WP supplemented rats (WDWP) compared
to the diabetic group (WD) (Figure 3C).
Macrophage-derived cytokines, such as IL-4, are
responsible for tissue formation. Therefore, we detected
IL-4 24 h after wounding. The results showed that IL-4
levels were decreased in the diabetic rats. We found that
whey protein significantly elevated the IL-4 levels in the
diabetic rats (WDWP), which were approximately twice
the level of the diabetic animals (WD), as shown in Fig-
ure 3D.
Whey protein stimulated neutrophil infiltration into
wound sites
The histological sections of wounded skin revealed that
the epidermal cell proliferation and migration, and the
dermal reorganization gradually improved and was com-
plete by day 8 in WDWP animals. However, the phases
of wound healing were delayed and disturbed in WD
counterparts and the epidermal cell migration only par-
tially covered the wound region. Additionally, hair folli-
cles, which reflect dermal contraction, were rarely
observed in the dermis (Figure 4A).
In the early stages of an inflammatory response, the
predominant cell type that infiltrates the tissue is neu-
trophils. Neutrophil infiltration peaks within the first 6
hours [18]. Neutrophil infiltration was significantly
depressed in diabetic rats compared to control and
WDWP rats at 6 and 24 h after wounding. Thus, dia-
betes leads to a quantitative reduction in the level of
neutrophil infiltration into the wound site up to 24 h
after wounding. On the other hand, the level of neutro-
phil infiltration was restored to control levels in the
WDWP rats (Figure 4B). Taken together, these findings
demonstrate that the early inflammatory response is
dramatically attenuated in WD rats and that supplemen-
tation of WDWP rats with WP effectively restores the
features of the early inflammatory response to levels
observed in control mice.
Discussion
Accelerating wound healing in diabetes is the aim of a
large number of studies. As a result of excessive ROS, a
disturbed early inflammatory phase of healing charac-
terizes diabetic wounds [19]. In this study, we have
demonstrated that wound closure is significantly shor-
tened in diabetic rats supplemented with WP in a cuta-
neous model of wound healing. Moreover, our data
clearly demonstrated that WP supplementation of dia-
betic animals reduced oxidative stress and restored mar-
kers of the inflammatory response to levels similar to
control animals.
Oxidative stress occurs due to an imbalance between
the production of ROS and the protection by cellular
antioxidants [20]. During the inflammatory phase, the
Figure 1 Wound closure rate in non-diabetic normal rats (WN),
diabetic rats (WD) and diabetic rats supplemented with whey
protein (WDWP). A: Wound closure rate at two days intervals
showing the effect of whey protein on wound healing in WDWP
rats that recorded a significantly faster closure rate than that of the
diabetic rats. B: External photograph showing wounds in the
different groups at D2 and D3. Wound contraction is obvious in the
WDWP animals at D3. No visible changes had occurred in the
diabetic wounds at the D3. Wound size was calculated by
determining the area of the wound each day in comparison to the
area of the standard square.
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Page 3 of 10Figure 2 Oxidative stress in non-diabetic normal rats (WN), diabetic rats (WD) and diabetic rats supplemented whey protein (WDWP).
MDA, NO and total glutathione were measured in liver tissues, while ROS was estimated in skin tissue. All oxidative markers were significantly
elevated in the diabetic rats. Whey protein restored the levels of these markers in WDWP rats to levels close to those of the control rats and
significantly increased glutathione levels.
Figure 3 A, B: ELISA estimation of both IL-1b and TNF-a levels at 6 h and 24 h in wounded non-diabetic normal rats (WN), wounded
diabetic rats (WD) and wounded diabetic rats supplemented with whey protein (WDWP). C,D: Gene expression of the IL-6 (6 h) and IL-4
(24 h) proteins in the three groups showing a notable effect of the whey protein on both cytokines after wounding.
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(H&E ×40, second row; H&E ×400, third row) and at the end of the experiment (H&E ×40). The second row of these sections shows
higher magnifications of the wound sites infiltrated with large number of inflammatory cells, especially neutrophils, in both WN and WDWP rats.
A small number of the inflammatory cells are shown in the section from WD rats (arrow head). B: Neutrophil infiltration in wound sites in non-
diabetic normal rats (WN), diabetic rats (WD) and diabetic rats supplemented whey protein (WDWP). A score between 0 (no infiltration) and 10
(neutrophil infiltration in most areas) for neutrophil infiltrations was given for each investigated section.
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phages causes tissue damage [21]. We found that the
levels of MDA, NO and ROS were elevated in diabetic
r a t sa n dt h a tW Pr e s t o r e dt h eo x i d a t i v em a r k e r si n
WDWP rats. Previous studies have shown that WP
plays an active role in iron transport [22], in the cyto-
toxic defense of neutrophils [23], and in scavenging free
radicals [24]. Indeed, a significant enhancement of glu-
tathione was observed in the WP supplemented rats in
this study. WP has been shown to be a potent inducer
of glutathione. The ability of cysteine to increase glu-
tathione levels is greater when it is delivered in whey
protein rather than as free cysteine [25].
Therefore, WP is able to reduce the effects of oxygen
radicals and lipid peroxidation by increasing the antioxi-
dant glutathione and thus stimulating the early normal
inflammatory events of the healing process. Accordingly,
WP has a potential role in stimulating the characteristic
inflammatory cytokines. WP restored high levels of both
IL-1b,T N F - a in diabetic rats supplemented with WP
(WDWP). IL-1b,T N F - a modulate the expression of the
chemokines and adhesion molecules necessary for the
recruitment of inflammatory cells to the site of injury
[26,27]. A significant increase in neutrophil infiltration
into the wound sites was observed in WDWP rats and
control rats compared in the diabetic rats. These find-
ings further suggest that WP inhibits ROS and other
oxidative markers and elevates neutrophil infiltration
during the early inflammatory response in WDWP rats.
We previously found that the in vitro chemotaxis of B
cells, T cells and bone marrow-derived dendritic cells
toward CCL-21 and CXCL-12 was significantly
increased in WP-treated mice [17].
Neutrophils are major producers of numerous cyto-
kines that serve as some of the earliest signals to acti-
vate keratinocytes and fibroblasts, thus initiating the
proliferative and remodeling phases of wound healing
[28,29]. Neutrophils are the first inflammatory cells to
infiltrate the wound site and play a key role during the
early inflammatory stage of wound healing by clearing
bacteria and phagocytosing cellular debris [30]. It was
found that bovine whey protein primes normal human
blood neutrophils by enhancing chemotaxis, phagocyto-
sis, oxidative burst, and degranulation [31].
Pradhan et al. [32] found that the post-injury expres-
sion of IL-6, IL-8, CXCR1, CXCR2, and GP-130 is sig-
nificantly less in diabetic wounds compared with non-
diabetic wounds. WP was found to stimulate the accu-
mulation of IL-1b, IL-8, IL-6, macrophage inflammatory
protein (MIP)-1a,M I P - 1 b and TNF-a [31]. Similarly,
we found that WP stimulated higher levels of IL-6 in
WDWP rats than diabetic rats.
In diabetic rats, lipid peroxidation of cellular and orga-
nelle membranes, disruption of the intracellular matrix,
and alteration of important protein enzymatic processes
causes tissue damage [21]. Tissue damage impairs
growth and proliferation of keratinocyte endothelial
cells, fibroblasts, and collagen metabolism [33,34], which
in turn can impair the healing process (delayed granula-
tion tissue formation, decreased collagen, and tissue
organization) [35]. We found poor re-epithelization and
dermal construction in the skin sections of WD rats. On
the other hand, stimulating the early normal inflamma-
tory events of the healing process with WP greatly
induced the normal re-epithelization and proliferation of
fibroblasts. This result was confirmed by the improve-
ment in the histological architecture of wounded skin in
WDWP rats compared to WD rats (Figure 4A). Further-
more, WP significantly elevated the level IL-4 in
WDWP in comparison to WD rats. IL-4 is a macro-
phage-derived cytokine that is responsible for tissue for-
mation (collagen production in fibroblasts) [36].
Therefore, there is a positive correlation between the
elevation of IL-4 and the normal reconstruction of the
dermis in WDWP rats.
Contraction is characterized by the centripetal move-
ment of the wound edge toward the center of the
wound. Wound contraction begins 4 to 5 days after
injury [37]. In our study, wound contraction was evident
in the wounds of WDWP at D3 and in the wounds of
control rats at D5 compared to D10 in the diabetic rats.
Both myofibroblasts and fibroblasts are thought to be
responsible for this process [38,39]. WP contains all
amino acids, including glutamine and the branched-
chain amino acids that are necessary for cell growth
[14]. Therefore, in addition to a supply of glutathione
and the appropriate essential amino acids, whey protein
enhanced the latter stages of wound healing, such as tis-
sue repair and remodeling, in diabetic rats. These find-
ings clearly explained the high wound closure rate and
the normal epithelization of wound healing in the
WDWP rats.
Taken together, the results of this work support the
hypothesis that the oxidative stability induced in diabetic
rats by WP contributes to the accelerated wound heal-
ing and immune stimulation observed in WDWP rats.
NFkB is required for the induction of pro-inflammatory
cytokines, such as IL-1b,T N F - a and IL-6 [40].
Although we did not address this in the present study,
oxidative stability induced by WP may mediate the acti-
vation of NFkB, leading to the activation of the inflam-
matory cascade and the stimulation of wound healing,
resulting in the faster wound closure rate in WDWP
rats.
Our findings explain the significant restoration of
inflammatory markers in whey protein-treated diabetic
rats. The current study demonstrated that WP induces
the early inflammatory response of cutaneous wound
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oxidative stress. There are currently no data on the use
of WP to treat wound healing impairment in diabetes.
This study may provide critical insight into future nutri-
tional intervention strategies designed to enhance early
wound healing in diabetic people. This strategy would
show whether this WP has a significant clinical impact.
Therefore, the potential role of whey protein in the
treatment of diabetic wounds needs to be intensively
investigated in future research focusing on patient-
oriented outcomes.
Materials and methods
Extraction of whey protein and animal diets
Camel milk was obtained from three breeds (Majaheem,
Maghateer and sofr) of camel from the Najd region in
Saudi Arabia. The milk was skimmed by centrifugation
at 5000 g for 20 min using a IEC Model K centrifuge,
[Boston, USA]. Skim milk was acidified to pH 4.3 using
1 M HCl. The precipitated casein was removed by cen-
trifugation, and the supernatant containing the whey
protein was saturated with ammonium sulfate (70%
saturation) and incubated overnight at 4°C. The precipi-
tated whey protein was collected by centrifugation and
dialyzed against distilled water for 48 h at 4°C using a
Spectra/Pro
® Membrane, MWCO 6000-8000 Da. The
obtained dialyzates were lyophilized using a Unitop
600SL, Virtis Company, Gardiner, New York 12525
USA and were kept at -20°C until use. The dialysate
containing undenatured whey proteins was freeze-dried
and refrigerated until use.
Experimental design
Adult male rats weighing 120-150 g were obtained from
the College of Pharmacy, King Saud University, Saudi
Arabia and housed in stainless steel wire cages (5 ani-
mals/cage) under pathogen-free conditions. All animal
procedures were conducted in accordance with the stan-
dards set forth in the guidelines for the care and use of
experimental animals by the Committee for the Purpose
of Control and Supervision of Experiments on Animals
(CPCSEA) and the National Institutes of Health (NIH)
protocol. The study protocol was approved by the Ani-
mal Ethics Committee of the Zoology Department, Col-
lege of Science, King Saud University. The animals were
maintained at 18-22°C on a 12:12 h light/dark cycle and
provided with food and water ad libitum.
The animals were assigned to three groups: 1) the first
group was remained as a wounded non-diabetic (WN)
control group and was given phosphate buffered saline,
2) the second group was a wounded diabetic group
(WD) given phosphate buffered saline, 3) the third
group was a wounded diabetic group orally supplemen-
ted with whey protein (WDWP) at a dose of 100 mg/kg
of body weight for 15 days pre-wounding and 15 days
post-wounding. Seven animals from each group were
sacrificed under mild diethyl ether anesthesia 6 h, 24 h
after wounding and at the end of the experiment.
Diabetic and wound models
The diabetic groups were intraperitoneally injected with
streptozotocin (65 mg/kg) to induce diabetes [41]. Strep-
tozotocin-injected animals exhibited massive glucosuria
and hyperglycemia within 5 days of injection. Diabetes
was confirmed in rats by measuring the fasting blood
glucose level (200-250 mg/dl) before use in this
experiment.
Rats were anaesthetized with isoflurane, and the back
of the rat was shaved and sterilized using an alcohol
swab. The wound biopsy model used in this experiment
was described previously [42] with little modification.
The shaved skin was pinched and folded, and the
wound was punched through the full thickness of the
folded skin to form a 2 × 5 mm rectangle below the
shoulder blades of each rat.
Measurement of wound closure
The procedure for measuring wound closure was pre-
viously described by Lim et al. [19]. Wounds from indi-
vidual rats were digitally photographed every day. A
standard rectangle equivalent in size to the initial
wound area was drawn beside the wound and used as a
reference. Wound size was calculated by determining
t h ea r e ao ft h ew o u n de a c hd a yi nc o m p a r i s o nt ot h e
area of the standard rectangle. Wound closure was
expressed as the ratio of the initial wound size to the
wound area (each day after wounding). A higher ratio
indicates faster wound closure.
Collection of blood and tissue samples
Two blood samples were immediately collected. The
first sample was used for serum analysis. Plasma was
isolated from the second sample using EDTA (ethylene-
diaminetetra acetic acid) as an anticoagulant. Samples of
plasma and serum were separated for analysis by centri-
fuging the blood for 15 minutes at 3000 rpm.
Estimation of glutathione
Glutathione (GSH) assay was carried out on tissue as
previously described [43]. Liver was removed and gently
rinsed in physiological saline. The fresh organ weights
were recorded, and organs were frozen until use. A 10%
(w/v) homogenate of each frozen tissue was prepared,
and the supernatant was used in the enzymatic assays.
Glutathione concentrations were measured by adding
100 μl of supernatant to 400 μl PBS [containing 200
mM monochlorobenzene (MCB) and 2 U/ml glu-
tathione S-transferase (per 100 μl)]. Glutathione
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absorbance of the reaction after 1 min at 340 nm using
an UV Visible Spectrometer (Ultrospec 2000, Pharmacia
Biotech). Glutathione standards were measured concur-
rently to obtain a standard curve that was used to calcu-
late GSH concentrations in samples. Results were
expressed as μg GSH/g tissue. Statistical comparisons of
GSH activities between controls and treatments in each
case were performed using Minitab statistical program
as detailed below.
Estimation of nitric oxide
Nitric Oxide was assayed as described by Oliveira et al.
[44]. Equal volumes of sulfanilamide (1.5% in 5% H3PO4)
and naphthylethylene diamine dihydrochloride (0.1% in
H2O) were mixed. An equal volume of working reagent
was mixed with 0.1 ml of each liver supernatant and
incubated for 15 min at room temperature. The absor-
bance was measured at 540 nm. The nitrite concentra-
tion was calculated by means of a NaNO3 standard
curve, and data were expressed as millimolar nitrite.
Estimation of lipid peroxidation
The peroxidation of the endogenous lipids in the liver
homogenates was estimated spectrophotometrically fol-
lowing the method described by Okhawa et al., [45] and
expressed in nanomoles of malondialdehyde (MDA) per
milliliter of homogenate (nmole/ml). A 0.5 ml aliquot of
the resulting supernatant was shaken with 2.5 ml of 20%
trichloroacetic acid (TCA). To the resulting mixture, 1
ml of 0.67% thiobarbituric acid (TBA) was added, and
the samples were shaken and incubated for 30 min in a
boiling water bath followed by immediate rapid cooling
in ice for 5 min. After cooling, 4 ml of n-butyl-alcohol
was added, and the samples were shaken well. The
resulting mixture was then centrifuged at 16,000 g for 5
min. The resultant n-butyl-alcohol layer was moved into
a separate tube, and MDA content was determined
spectrophotometrically at 535 nm using an UV Visible
Spectrometer (Ultrospec 2000, Pharmacia Biotech).
ROS measurement
ROS levels were determined using 2,7-dichlorodihydro-
fluorescein diacetate (H2DCF-DA) (Beyotime Institute of
Biotechnology, Haimen, China). The supernatant from skin
homogenates were directly treated with 10 μMH 2 D C F - D A
dissolved in 1 ml PBS at 37°C for 20 min. The fluorescence
intensity was monitored using an excitation wavelength of
488 nm and an emission wavelength of 530 nm.
ELISA assay for the inflammatory cytokines IL-1b and
TNF-a
Sera were tested for IL-1b and TNF-a by ELISA accord-
ing to the manufacturer’s instructions for the
corresponding rat immunoassay kits (BioSource Interna-
tional Inc., USA). The optical densities (OD) were mea-
sured at 405 nm. The detection limits were set
according to the log-log correlative coefficient of the
standard curve.
PCR determination of IL-4 and IL-6 levels
Total RNA was isolated from tissues used in this study,
and mRNA was purified using Fermentas kit. The
cDNA was reverse transcribed using an Oligo-dT cDNA
extraction kit (Promega). cDNA was prepared using a
PCR-select™cDNA subtraction kit (Clontech, Heidel-
berg, Germany) according to the manufacturer’sprotocol
with a few modifications.
cDNA for PCR was prepared from tissues by RT-PCR
using the primers 5’-ATGGGTCTCAGCCCCCACCT-
3’and5’- CAAGTATTTCCCTCGTAGGA -3’aS forward
and reverse primers, respectively, for IL-4 and 5’-C A A -
GAGACTTCCAGCCAGTTGC -3’AND 5’-T A G C -
CACTCCTTCTGTGACTCT-3’ FOR IL-6 Using rat
tissue cDNA as a template. The PCR amplification was
performed using a PTC-100™(MJ, USA.). The PCR
reaction used the following program: the reaction mix-
ture was incubated at 95°C for 10 min, denatured for 1
min at 95°C, annealed for 30 sec at the optimal tem-
perature (54°C for IL-4 and 49°C for IL-6) and extended
at 72°C for 2 min. The program was repeated for 32
cycles and followed by an incubation at 72°C for 10 min
for final extension. The results were analyzed by agarose
gel electrophoresis.
Histological analyses
Histological preparation of wound tissues was previously
described by Drury and Wallington [46]. The rats were
euthanized with an overdose of isoflurane, and tissue
samples were collected from the wound sites to examine
neutrophil infiltration into the wound area. Wounds
were removed from four rats from each treatment
group at 6 h, 24 h and at the end of the study period
a f t e rw o u n d i n gb yc u t t i n gas q u a r ea r e at h a te n c o m -
passed the entire wound site. The harvested tissues were
immediately stored in a 10% formaldehyde solution in
phosphate-buttered saline, washed in PBS, dehydrated in
series of alcohol dilutions and embedded in paraffin.
Microtome sections were cut vertically across the
wound site and adhered to slides prior to staining with
hematoxylin and eosin. Photographs of the sections in
w o u n ds i t ew e r et a k e n ,a n dt h ei m a g e sw e r ed i g i t i z e d
using Adobe Photoshop (Adobe Systems, Mountain
View, CA). Neutrophil infiltration was scored according
to Dommels et al. [47]. A rating score between 0 (no
infiltration) and 10 (neutrophils involved in most areas)
for inflammatory infiltrations, especially neutrophils, was
assigned for each investigated section. Sections from at
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infiltrations at the wound site.
Statistical analysis
Statistical analysis was performed using the MINITAB
software (MINITAB, State College, PA, Version 13.1,
2002). The data from experiments were first tested for
normality using the Anderson Darling test and for var-
iance homogeneity prior to any further statistical analy-
s i s .T h ed a t aw e r en o r m a l l yd i s t r i b u t e d ,a n dt h e
variances were homogeneous; thus, one-way ANOVA
was used to determine overall effects of the treatments
followed by individual comparison using Tukey’sP a i r -
wise comparison. The results are expressed as the
means ± standard deviations (SD). P-values > 0.05 were
considered statistically non-significant, and P-values <
0.05 were considered statistically significant.
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